Skip to main content

Funded Startups in Allschwil, Switzerland

Updated August 2026

Explore 9 recently funded startups in Allschwil, Switzerland.Access verified founder contact information and funding data.

Total Companies
9
Total Funding
$587.3M
Avg Funding
$65.3M
Industries
4

Export 9 Companies with Verified Contacts

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
$90.0M
raised

Bright Peak is a biotech company that develops a portfolio of immunotherapies for the treatment of cancer and autoimmune diseases.

Jun 2024
Series C

Founder Contacts

41,000+ verified contacts

Biotechnology
$636K
raised

Cancentus is a cancer treatment company that provides AI-based disease discovery solutions.

Apr 2026
Convertible Note

Founder Contacts

41,000+ verified contacts

Biotechnology
$549K
raised

Phialogics is focuses on developing next-generation biologics to balance the immune response in both acute and long-term inflammation.

Oct 2023
Grant

Founder Contacts

41,000+ verified contacts

$545K
raised

Salvina Therapeutics is developing novel antibodies targeting TNF to overcome efficacy barriers in inflammatory and autoimmune diseases.

Oct 2023
Grant

Founder Contacts

41,000+ verified contacts

Bioinformatics
$4K
raised

The most comprehensive blood test, via multi-omics and AI, for disease risk identification and prevention planning.

Aug 2024
Grant

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 9 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Biotechnology
$313.9M
raised

The purpose of Idorsia is to discover, develop and commercialize innovative medicines to help more patients.

Jun 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Health Care
$188K
raised

GlioCART is a University of Basel spin-out developing the first CAR-T cell therapy for glioblastoma (GBM), an aggressive brain cancer,

Nov 2025
Seed

Founder Contacts

41,000+ verified contacts

$181.4M
raised

ALENTIS Therapeutics is a Swiss-French biotech company developing novel therapeutics in advanced liver disease and cancer.

Nov 2024
Series D

Founder Contacts

41,000+ verified contacts

Synendos Therapeutics develops a class of small molecules for the treatment of anxiety and stress-related disorders.

Sep 2025
Grant

Founder Contacts

41,000+ verified contacts